D
Greenwich LifeSciences, Inc. GLSI
$11.67 -$0.26-2.18% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 52.19% 98.77% 282.95% 26.74% -4.02%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 52.03% 29.37% 185.06% 9.04% 52.27%
Operating Income -52.03% -29.37% -185.06% -9.04% -52.27%
Income Before Tax -54.42% -31.75% -192.72% -11.58% -60.08%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -54.42% -31.75% -192.72% -11.58% -60.08%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -54.42% -31.75% -192.72% -11.58% -60.08%
EBIT -52.03% -29.37% -185.06% -9.04% -52.27%
EBITDA -52.04% -29.38% -185.12% -9.04% -52.30%
EPS Basic -49.01% -28.65% -186.01% -9.08% -59.43%
Normalized Basic EPS -49.13% -28.62% -186.08% -9.11% -59.34%
EPS Diluted -49.01% -28.65% -186.01% -9.08% -59.43%
Normalized Diluted EPS -49.13% -28.62% -186.08% -9.11% -59.34%
Average Basic Shares Outstanding 3.60% 2.43% 2.33% 2.29% 0.46%
Average Diluted Shares Outstanding 3.60% 2.43% 2.33% 2.29% 0.46%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --